WallStreetZenWallStreetZen

NASDAQ: CLSD
Clearside Biomedical Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CLSD

Based on 3 analysts offering 12 month price targets for Clearside Biomedical Inc.
Min Forecast
$4.00+214.96%
Avg Forecast
$5.33+319.92%
Max Forecast
$6.00+372.44%

Should I buy or sell CLSD stock?

Based on 3 analysts offering ratings for Clearside Biomedical Inc.
Buy
Strong Buy
0 analysts 0%
Buy
3 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CLSD stock forecasts and price targets.

CLSD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Top 34%
67
BuyReiterates$6.00+372.44%2023-06-01
JMP Securities
Top 7%
94
BuyReiterates$6.00+372.44%2023-04-28
Needham
Bottom 10%
10
BuyReiterates$4.00+214.96%2023-04-20

1 of 1

Forecast return on equity

Is CLSD forecast to generate an efficient return?
Company
N/A
Industry
0.07%
Market
71.69%

Forecast return on assets

Is CLSD forecast to generate an efficient return on assets?
Company
N/A
Industry
0.1%

CLSD revenue growth forecast

How is CLSD forecast to perform vs Biotechnology companies and vs the US market?
Company
168.36%
Industry
40.1%
Market
8.46%
CLSD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CLSD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CLSD vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CLSD$1.27$5.33+319.92%Buy
DMAC$2.92N/AN/A
SYRS$3.74$15.75+321.12%Strong Buy
ELYM$2.96$6.00+102.70%Hold
CYT$2.16$2.33+8.01%Hold
View Top Biotech Stocks

Clearside Biomedical Stock Forecast FAQ

Is Clearside Biomedical Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: CLSD) stock is to Buy CLSD stock.

Out of 3 analysts, 0 (0%) are recommending CLSD as a Strong Buy, 3 (100%) are recommending CLSD as a Buy, 0 (0%) are recommending CLSD as a Hold, 0 (0%) are recommending CLSD as a Sell, and 0 (0%) are recommending CLSD as a Strong Sell.

If you're new to stock investing, here's how to buy Clearside Biomedical stock.

What is CLSD's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: CLSD) forecast ROE is N/A, which is considered weak.

What is CLSD's Price Target?

According to 3 Wall Street analysts that have issued a 1 year CLSD price target, the average CLSD price target is $5.33, with the highest CLSD stock price forecast at $6.00 and the lowest CLSD stock price forecast at $4.00.

On average, Wall Street analysts predict that Clearside Biomedical's share price could reach $5.33 by Jun 1, 2024. The average Clearside Biomedical stock price prediction forecasts a potential upside of 319.92% from the current CLSD share price of $1.27.

What is CLSD's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: CLSD) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.1%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.